Literature DB >> 2370079

Effects of the MHC on hormonal induction of mammary tumors and function of hypophyseal isografts in the mouse.

G Röpcke1, C J Moen, A A Hart, P Demant.   

Abstract

While the role of the H-2 complex in the resistance to virally induced tumors has been extensively studied, little is known about its influence on the development of epithelial tumors of non-viral etiology, although such tumors are most prevalent in humans. Therefore, we analyzed the role of the H-2 complex in susceptibility to mammary tumors induced by hormonal stimulation from heterotopic hypophyseal isografts in H-2 congenic strains from C57BL/10, BALB/c, and O20/A backgrounds. This method of induction allows an assessment of the effect of H-2 genes on the function of various organs involved in this process. We found that the tumor susceptibility genes map to two segments: I-E-S, and to the right of S. The mechanisms by which the H-2 complex affects the induction of mammary tumors in C57BL/10 congenic strains seem to include an influence on several factors involved in the hormonal stimulation, because the susceptible B10 congenic strains have higher plasma levels of prolactin and the H-2 complex also affects the growth of hypophyseal isografts. Their size correlates with tumor development in individual mice in the resistant C57BL/10 congenic strains. We reported previously H-2-dependent differences in levels of the estrogen receptor in hypophysis. For this study, we measured the levels of estrogen receptors in uteri to asses the tissue specificity of this effect of H-2. However, no influence of the H-2 complex on estrogen receptor levels was observed in uteri. Strains from BALB/c and O20 backgrounds developed mammary tumors much earlier than the B10 congenic strains, indicating a strong influence of non-H-2 genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370079     DOI: 10.1007/bf02115009

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  23 in total

1.  Recombinant congenic strains--a new tool for analyzing genetic traits determined by more than one gene.

Authors:  P Démant; A A Hart
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Allelic forms of a gene controlling the female immune response to the male antigen in mice.

Authors:  D W Bailey
Journal:  Transplantation       Date:  1971-04       Impact factor: 4.939

Review 3.  Molecular heterogeneity of H-2 antigens.

Authors:  P Démant; D Iványi; M Oudshoorn-Snoek; J Calafat; M H Roos
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

4.  H-2-controlled genetic susceptibility to pulmonary adenomas induced by urethane and 4-nitroquinoline 1-oxide in A/Wy congenic strains.

Authors:  N Miyashita; K Moriwaki
Journal:  Jpn J Cancer Res       Date:  1987-05

5.  Differences in H-2 recombinant mice in the beta-naphthoflavone inducibility of the mixed function monooxygenase, P1-450.

Authors:  A Koizumi; R L Walford; L Hasegawa
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).

Authors:  S Gattoni-Celli; C G Willett; D B Rhoads; B Simon; R M Strauss; K Kirsch; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs.

Authors:  L C Oomen; M A van der Valk; A A Hart; P Demant; P Emmelot
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

8.  Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 complex.

Authors:  L C Oomen; M A van der Valk; A A Hart; P Demant
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

9.  Glucocorticoid-induced cleft palate in the mouse: two major histocompatibility complex, H-2, loci with different mechanisms.

Authors:  J J Bonner; M L Tyan
Journal:  Genetics       Date:  1983-02       Impact factor: 4.562

10.  Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts.

Authors:  M Hurme; P R Chandler; C M Hetherington; E Simpson
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  3 in total

1.  VARS2 V552V variant as prognostic marker in patients with early breast cancer.

Authors:  Yee Soo Chae; Soo Jung Lee; Joon Ho Moon; Byung Woog Kang; Jong Gwang Kim; Sang Kyun Sohn; Jin Hyang Jung; Ho Yong Park; Ji Young Park; Hye Jung Kim; Sang-Woo Lee
Journal:  Med Oncol       Date:  2010-05-26       Impact factor: 3.064

2.  New microsatellite size variants as markers for a cross-over hotspot in the C4-H-2D region.

Authors:  M Snoek; H van Vugt; P C Groot
Journal:  Mamm Genome       Date:  1994-03       Impact factor: 2.957

3.  A susceptibility gene for alveolar lung tumors in the mouse maps between Hsp70.3 and G7 within the H2 complex.

Authors:  R J Fijneman; L C Oomen; M Snoek; P Demant
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.